{
    "clinical_study": {
        "@rank": "82169", 
        "arm_group": [
            {
                "arm_group_label": "Mastectomy", 
                "description": "Patients treated with mastectomy without reconstruction"
            }, 
            {
                "arm_group_label": "Reconstruction", 
                "description": "Patients treated with mastectomy followed by reconstruction"
            }
        ], 
        "brief_summary": {
            "textblock": "A cross sectional study to determine the prevalence of persistent pain after reconstructive\n      surgery after mastectomy for breast cancer, with a comparative analysis of a cohort treated\n      with mastectomy without reconstruction."
        }, 
        "brief_title": "Persistent Pain After Reconstruction Following Mastectomy", 
        "completion_date": {
            "#text": "April 2008", 
            "@type": "Actual"
        }, 
        "condition": [
            "Breast Cancer", 
            "Chronic Pain"
        ], 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "The aim of the study is to determine if reconstruction of the breast after mastectomy\n      increases the risk of reporting persistent pain 2-3 years after surgery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with unilateral primary breast cancer aged 18-70 years\n\n        Exclusion Criteria:\n\n          -  recurrent cancer\n\n          -  other malignancy\n\n          -  emigration\n\n          -  non-standardized treatment"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Nationwide cross-sectional cohort"
            }
        }, 
        "enrollment": {
            "#text": "1352", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01738048", 
            "org_study_id": "H-D-2007-0099B"
        }, 
        "intervention": {
            "arm_group_label": "Reconstruction", 
            "description": "Reconstructive surgery after mastectomy, either by expander or autologous tissue. Includes both primary and secondary reconstruction", 
            "intervention_name": "Reconstruction", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pain", 
            "Neuropathic pain", 
            "Chronic pain"
        ], 
        "lastchanged_date": "November 29, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "Rigshospitalet"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "2", 
        "official_title": "Persistent Pain After Reconstruction Following Mastectomy", 
        "overall_official": {
            "affiliation": "Rigshospitalet, University of Copenhagen", 
            "last_name": "Kenneth G Andersen, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: The Regional Committee on Biomedical Research Ethics"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2008", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The risk of developing persistent if reconstructed compared to patients mastectomized without reconstruction expressed as an odds ratio.", 
            "measure": "The risk of developing persistent if reconstructed", 
            "safety_issue": "No", 
            "time_frame": "Cross-sectional, 2-3 years after surgery for breast cancer"
        }, 
        "reference": {
            "PMID": "21435953", 
            "citation": "Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011 Jul;12(7):725-46. Epub 2011 Mar 24. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01738048"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rigshospitalet, Denmark", 
            "investigator_full_name": "Kenneth Geving Andersen", 
            "investigator_title": "Physician, research fellow", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Self reported pain expressed as a percentage of the population of patients reconstructed with expander and autologous tissue. Pain intensity measured with a numerical rating scale 0-10, divided in mild (NRS 1-3), moderate (4-6) and severe pain (7-10). Patients regarded as having clinically relevant pain: NRS 4 or above, at least at a weekly basis.", 
                "measure": "Prevalence of persistent pain after reconstruction after mastectomy", 
                "safety_issue": "No", 
                "time_frame": "Cross-sectional, 2-3 years after surgery for breast cancer"
            }, 
            {
                "measure": "Prevalence of sensory disturbances after reconstruction after mastectomy", 
                "safety_issue": "No", 
                "time_frame": "Cross-sectional, 2-3 years after surgery for breast cancer"
            }
        ], 
        "source": "Rigshospitalet, Denmark", 
        "sponsors": {
            "collaborator": {
                "agency": "Danish Breast Cancer Cooperative Group", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Rigshospitalet, Denmark", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "November 2012"
    }
}